Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Systemic Inflammatory Response Syndrome | 12 | 2025 | 209 | 1.480 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 5 | 2023 | 74 | 1.210 |
Why?
|
| Coronary Vessel Anomalies | 10 | 2021 | 284 | 1.050 |
Why?
|
| Coronary Vessels | 6 | 2023 | 530 | 0.900 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 773 | 0.850 |
Why?
|
| Myocarditis | 2 | 2022 | 130 | 0.820 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2021 | 16 | 0.710 |
Why?
|
| Pericarditis | 1 | 2022 | 44 | 0.710 |
Why?
|
| Gastrostomy | 1 | 2021 | 88 | 0.670 |
Why?
|
| Pneumonia, Viral | 2 | 2022 | 379 | 0.660 |
Why?
|
| Hyperglycemia | 1 | 2022 | 234 | 0.650 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 158 | 0.640 |
Why?
|
| Heart Defects, Congenital | 6 | 2025 | 1892 | 0.620 |
Why?
|
| Pulmonary Atresia | 1 | 2019 | 48 | 0.600 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 31 | 0.600 |
Why?
|
| Hospitalists | 1 | 2019 | 46 | 0.590 |
Why?
|
| Tracheostomy | 1 | 2021 | 215 | 0.580 |
Why?
|
| Coronary Circulation | 1 | 2019 | 187 | 0.570 |
Why?
|
| Pneumonia | 1 | 2022 | 342 | 0.570 |
Why?
|
| Child | 39 | 2025 | 26098 | 0.570 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2025 | 1176 | 0.550 |
Why?
|
| Vaccination | 3 | 2023 | 1036 | 0.550 |
Why?
|
| Ventricular Function, Left | 6 | 2025 | 545 | 0.530 |
Why?
|
| Immunoglobulins, Intravenous | 4 | 2023 | 147 | 0.500 |
Why?
|
| Pericardium | 1 | 2017 | 107 | 0.490 |
Why?
|
| Teratoma | 1 | 2017 | 123 | 0.490 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 108 | 0.490 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2020 | 275 | 0.450 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 787 | 0.430 |
Why?
|
| Gestational Age | 2 | 2017 | 1215 | 0.430 |
Why?
|
| Hospitalization | 2 | 2025 | 1925 | 0.410 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2025 | 358 | 0.410 |
Why?
|
| Fetal Diseases | 1 | 2017 | 460 | 0.400 |
Why?
|
| Connective Tissue Diseases | 2 | 2023 | 32 | 0.390 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2023 | 55 | 0.370 |
Why?
|
| Coronary Angiography | 6 | 2021 | 459 | 0.360 |
Why?
|
| Child, Preschool | 20 | 2025 | 14945 | 0.360 |
Why?
|
| Fetal Heart | 3 | 2017 | 135 | 0.360 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2025 | 1000 | 0.350 |
Why?
|
| Coronary Aneurysm | 2 | 2023 | 31 | 0.340 |
Why?
|
| Magnetic Resonance Imaging, Cine | 5 | 2025 | 173 | 0.340 |
Why?
|
| Humans | 52 | 2025 | 130931 | 0.340 |
Why?
|
| Infliximab | 2 | 2021 | 66 | 0.320 |
Why?
|
| Male | 35 | 2025 | 64823 | 0.310 |
Why?
|
| Aorta, Thoracic | 3 | 2021 | 539 | 0.310 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2018 | 276 | 0.300 |
Why?
|
| Adolescent | 22 | 2025 | 20814 | 0.290 |
Why?
|
| Female | 33 | 2025 | 70755 | 0.280 |
Why?
|
| Myocardial Perfusion Imaging | 4 | 2021 | 55 | 0.280 |
Why?
|
| Echocardiography | 6 | 2025 | 1135 | 0.280 |
Why?
|
| Infant | 13 | 2025 | 13210 | 0.260 |
Why?
|
| Retrospective Studies | 13 | 2025 | 17485 | 0.260 |
Why?
|
| Prenatal Diagnosis | 2 | 2025 | 644 | 0.260 |
Why?
|
| Myocardial Contraction | 2 | 2019 | 240 | 0.250 |
Why?
|
| Echocardiography, Doppler | 2 | 2019 | 165 | 0.250 |
Why?
|
| Glucocorticoids | 3 | 2023 | 350 | 0.240 |
Why?
|
| Stroke Volume | 3 | 2023 | 531 | 0.230 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 4008 | 0.220 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2025 | 28 | 0.220 |
Why?
|
| Immune System Diseases | 1 | 2025 | 52 | 0.220 |
Why?
|
| Exercise | 2 | 2021 | 865 | 0.210 |
Why?
|
| United States | 11 | 2025 | 11718 | 0.200 |
Why?
|
| Cardiac Catheterization | 5 | 2020 | 635 | 0.200 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 863 | 0.200 |
Why?
|
| Fractional Flow Reserve, Myocardial | 2 | 2021 | 54 | 0.200 |
Why?
|
| Patient Care Team | 2 | 2025 | 558 | 0.200 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 539 | 0.190 |
Why?
|
| Time Factors | 6 | 2025 | 6275 | 0.180 |
Why?
|
| Health Status Disparities | 1 | 2025 | 275 | 0.180 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8542 | 0.180 |
Why?
|
| Disease Management | 3 | 2025 | 559 | 0.180 |
Why?
|
| Aftercare | 1 | 2022 | 154 | 0.170 |
Why?
|
| Shock | 1 | 2022 | 96 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 321 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 179 | 0.170 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 60 | 0.170 |
Why?
|
| Syncope | 1 | 2021 | 48 | 0.160 |
Why?
|
| Vascular Resistance | 2 | 2018 | 184 | 0.160 |
Why?
|
| Fever | 2 | 2021 | 311 | 0.160 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 19 | 0.160 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3799 | 0.160 |
Why?
|
| Weight Gain | 1 | 2022 | 384 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2021 | 1220 | 0.150 |
Why?
|
| Risk Factors | 9 | 2022 | 10901 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 5257 | 0.150 |
Why?
|
| Longevity | 1 | 2020 | 176 | 0.150 |
Why?
|
| Liver Transplantation | 2 | 2019 | 1124 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2022 | 505 | 0.140 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 32 | 0.140 |
Why?
|
| Pandemics | 2 | 2022 | 1157 | 0.140 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2019 | 120 | 0.140 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 2287 | 0.140 |
Why?
|
| Prospective Studies | 8 | 2024 | 6443 | 0.140 |
Why?
|
| MEDLINE | 1 | 2017 | 18 | 0.140 |
Why?
|
| Mitral Valve | 2 | 2016 | 252 | 0.130 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 296 | 0.130 |
Why?
|
| Aorta | 2 | 2017 | 534 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 310 | 0.130 |
Why?
|
| Myocardial Bridging | 1 | 2017 | 14 | 0.130 |
Why?
|
| Age Factors | 6 | 2020 | 2866 | 0.130 |
Why?
|
| Diseases in Twins | 1 | 2017 | 90 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2022 | 365 | 0.130 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 84 | 0.130 |
Why?
|
| Survival Rate | 2 | 2019 | 2138 | 0.130 |
Why?
|
| Aortic Coarctation | 1 | 2017 | 98 | 0.130 |
Why?
|
| Chest Pain | 1 | 2017 | 125 | 0.130 |
Why?
|
| Incidence | 2 | 2022 | 3327 | 0.130 |
Why?
|
| Computed Tomography Angiography | 4 | 2020 | 214 | 0.130 |
Why?
|
| Risk Assessment | 4 | 2020 | 3675 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2016 | 115 | 0.120 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2015 | 3 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2017 | 172 | 0.120 |
Why?
|
| Cholic Acids | 1 | 2015 | 16 | 0.120 |
Why?
|
| Athletes | 1 | 2016 | 73 | 0.120 |
Why?
|
| Hypertension | 1 | 2024 | 1357 | 0.120 |
Why?
|
| Drainage | 1 | 2017 | 254 | 0.120 |
Why?
|
| Pregnancy | 5 | 2025 | 7558 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 36 | 0.110 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2015 | 22 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 485 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 555 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 202 | 0.110 |
Why?
|
| Hemodynamics | 4 | 2022 | 835 | 0.110 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 45 | 0.110 |
Why?
|
| Hyperoxia | 1 | 2016 | 135 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 630 | 0.100 |
Why?
|
| Family | 1 | 2017 | 588 | 0.100 |
Why?
|
| Texas | 2 | 2019 | 3604 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 212 | 0.100 |
Why?
|
| Quality of Life | 2 | 2021 | 2096 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2015 | 162 | 0.100 |
Why?
|
| Registries | 1 | 2020 | 1591 | 0.100 |
Why?
|
| Norwood Procedures | 1 | 2014 | 103 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 549 | 0.090 |
Why?
|
| Adult | 5 | 2024 | 31541 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2017 | 873 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2024 | 5096 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 772 | 0.080 |
Why?
|
| Cardiology | 1 | 2014 | 505 | 0.070 |
Why?
|
| Exercise Test | 2 | 2020 | 245 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2025 | 1904 | 0.070 |
Why?
|
| Receptors, LDL | 2 | 2019 | 106 | 0.070 |
Why?
|
| Biomechanical Phenomena | 2 | 2019 | 263 | 0.070 |
Why?
|
| Length of Stay | 2 | 2025 | 1389 | 0.060 |
Why?
|
| Scrub Typhus | 1 | 2025 | 11 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3120 | 0.060 |
Why?
|
| North America | 1 | 2025 | 256 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 120 | 0.050 |
Why?
|
| Triage | 1 | 2025 | 152 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 10040 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 463 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2025 | 161 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 1441 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2023 | 48 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2024 | 200 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 896 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 421 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2022 | 180 | 0.040 |
Why?
|
| Prednisolone | 1 | 2021 | 69 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 269 | 0.040 |
Why?
|
| Syncope, Vasovagal | 1 | 2021 | 6 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2021 | 17 | 0.040 |
Why?
|
| Platelet Count | 1 | 2021 | 141 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 281 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2021 | 98 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 12858 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 788 | 0.040 |
Why?
|
| Algorithms | 2 | 2020 | 1680 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 448 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 78 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 501 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 722 | 0.040 |
Why?
|
| Aspirin | 1 | 2021 | 213 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 208 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 298 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2019 | 76 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 72 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2024 | 1352 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 216 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 589 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2019 | 249 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 122 | 0.040 |
Why?
|
| Umbilical Arteries | 1 | 2018 | 99 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 82 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 298 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 330 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1473 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 225 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 310 | 0.030 |
Why?
|
| Replantation | 1 | 2017 | 52 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 774 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3067 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 481 | 0.030 |
Why?
|
| Critical Care | 1 | 2022 | 678 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1344 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 204 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2191 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2021 | 980 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 529 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 515 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1703 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 875 | 0.030 |
Why?
|
| Heart Septum | 1 | 2015 | 44 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 584 | 0.030 |
Why?
|
| Diastole | 1 | 2015 | 175 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 130 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1248 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2014 | 74 | 0.030 |
Why?
|
| Heart Atria | 1 | 2016 | 335 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2016 | 449 | 0.020 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 338 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 296 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 444 | 0.020 |
Why?
|
| Aged | 2 | 2022 | 21134 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4930 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 1444 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2950 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2681 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 3161 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 6144 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 28735 | 0.010 |
Why?
|